6/17/2025
6/17/2025
Our goal is to develop predictive monitoring for early diagnosis of subacute, potentially catastrophic illness. To date, our focus has been on premature infants in an intensive care unit.The clinical…
6/17/2025
Dr. Ragosta is the principal or co-principal investigator on numerous multi-center clinical trials, including the EXCEL trial (left main PCI VS CAB6) and both the PARTNER trail (trans-catheter aortic valve…
6/17/2025
1) Activation of blood vessel smooth muscle primarily involves pathways which increase calcium and myosin phosphorylation resulting in contraction. Most recently my laboratory has been interested in contractile mechanisms beyond…
6/17/2025
Novel devices and medical therapies in the cardiovascular catheterization laboratory
6/17/2025
6/17/2025
Project 1: Early Noninvasive Detection of Myocardial Microvascular Dysfunction in Diabetes Brief Description: Type 2 diabetes has become an epidemic in the United States. Cardiovascular disease is the most common cause of…
6/17/2025
6/17/2025
Our mission is to understand how signaling molecules mediate cardiomyocyte growth, hypertrophy, and heart failure. We use novel approaches based on fruit fly genetics to identify genes that cause or…
